$212,400
＋18%
Director
2024
$213k
40 hrs/wk
Director at Seattle Institute for Biomedical and Clinical Research
Fiscal year ended September 30, 2024. Published on January 25, 2026.
Total compensation
Thomas Bundt Ph.D. Fache has been listed as an employee of Seattle Institute for Biomedical and Clinical Research in Form 990 filings since fiscal year 2022. Total compensation for Thomas Bundt Ph.D. Fache has increased by 18% from 2022 to 2024.